Surgical templates for inguinal lymph node dissection in cN0 penile cancer: A comparative study. 2023

Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

Modified and superficial inguinal lymph node dissection (MILD and SILD) are the 2 widely used templates for surgical staging of clinically node negative (cN0) penile cancer (PeCa); however, no previous reports have compared their outcomes. We compared these 2 surgical templates for oncological outcomes and complications. We retrospectively reviewed records of cN0 PeCa patients who underwent MILD/SILD at our cancer care center from January 2013 to December 2019. Patients who developed a penile recurrence during follow up were excluded from analysis of oncological outcomes. The 2 groups (MILD and SILD) were compared for baseline clinico-pathological characteristics. The primary outcome was the groin recurrence free survival (gRFS). Secondary outcomes included the false negative rate (FNR) and disease free survival (DFS) for both templates and also the post-operative wound related complication. Of the 146 patients with intermediate and high risk N0 PeCa, 74 (50.7%) and 72 (49.3%) underwent MILD and SILD respectively. The 2 groups were comparable with regards to the distribution of T stage, tumor grade and the proportion of intermediate and high-risk patients. At a median follow up of 34 months (47 for SILD and 23 for MILD), a total of 5 groin recurrences were encountered; all of them occurred in the MILD group. The gRFS and DFS for the MILD group was 93.2% and 91.8% respectively; while that for the SILD group was 100% and 94.4% respectively. Too few events had occurred to determine any statistically significant difference. The FNR for MILD and SILD was 26.3% and 0% respectively. The overall complication rate was significantly higher in the SILD group (46% vs 20.3%, p=0.001), especially for Clavien Dindo 3A complications. MILD can fail to pick up micro-metastatic disease in a small proportion of cN0 PeCa patients, while SILD provides better oncological clearance with no groin recurrences. This oncological superiority comes at the cost of a higher incidence of wound-related complications.

UI MeSH Term Description Entries
D007264 Inguinal Canal The tunnel in the lower anterior ABDOMINAL WALL through which the SPERMATIC CORD, in the male; ROUND LIGAMENT, in the female; nerves; and vessels pass. Its internal end is at the deep inguinal ring and its external end is at the superficial inguinal ring. Inguinal Ring,Canal, Inguinal,Canals, Inguinal,Inguinal Canals,Inguinal Rings,Ring, Inguinal,Rings, Inguinal
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010412 Penile Neoplasms Cancers or tumors of the PENIS or of its component tissues. Cancer of Penis,Penile Cancer,Cancer of the Penis,Neoplasms, Penile,Neoplasms, Penis,Penis Cancer,Penis Neoplasms,Cancer, Penile,Cancer, Penis,Cancers, Penile,Cancers, Penis,Neoplasm, Penile,Neoplasm, Penis,Penile Cancers,Penile Neoplasm,Penis Cancers,Penis Neoplasm
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D021701 Sentinel Lymph Node Biopsy A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm. Biopsy, Sentinel Lymph Node,Lymph Node Biopsy, Sentinel

Related Publications

Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
January 2008, International braz j urol : official journal of the Brazilian Society of Urology,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
June 2023, EJNMMI research,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
December 2020, Translational andrology and urology,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
March 2022, Urology,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
April 2018, Der Urologe. Ausg. A,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
January 2017, Investigative and clinical urology,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
January 2021, Frontiers in surgery,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
July 2013, Urologic oncology,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
October 2014, Hinyokika kiyo. Acta urologica Japonica,
Ganesh K Bakshi, and Mahendra Pal, and Deep Kumar Jain, and Amandeep Arora, and Ashwin Tamhankar, and Priyamvada Maitre, and Vedang Murthy, and Arunkumar J, and Archi Agrawal, and Santosh Menon, and Amit Joshi, and Philippe E Spiess, and Gagan J Prakash
August 2015, BJU international,
Copied contents to your clipboard!